Keshari Thakali
Concepts (277)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vasoconstriction | 8 | 2009 | 60 | 1.570 |
Why?
| Maternal Nutritional Physiological Phenomena | 4 | 2020 | 51 | 1.250 |
Why?
| Placenta | 3 | 2020 | 135 | 1.240 |
Why?
| Obesity | 7 | 2020 | 1202 | 1.210 |
Why?
| Umbilical Cord | 3 | 2017 | 33 | 1.180 |
Why?
| DNA Methylation | 4 | 2020 | 574 | 1.120 |
Why?
| Aorta, Thoracic | 8 | 2008 | 90 | 0.970 |
Why?
| Muscle, Smooth, Vascular | 8 | 2013 | 140 | 0.920 |
Why?
| Endothelin-1 | 5 | 2007 | 30 | 0.880 |
Why?
| Hydrogen Peroxide | 3 | 2006 | 142 | 0.790 |
Why?
| Pregnancy Complications | 5 | 2020 | 384 | 0.780 |
Why?
| Venae Cavae | 4 | 2007 | 9 | 0.730 |
Why?
| Veins | 4 | 2022 | 74 | 0.710 |
Why?
| Vasodilation | 3 | 2011 | 106 | 0.700 |
Why?
| Hypertension | 6 | 2013 | 564 | 0.630 |
Why?
| Weight Gain | 3 | 2019 | 243 | 0.620 |
Why?
| Calcium Channels, L-Type | 3 | 2017 | 63 | 0.610 |
Why?
| Adipocytes, Brown | 1 | 2016 | 10 | 0.590 |
Why?
| Thermogenesis | 1 | 2016 | 22 | 0.590 |
Why?
| Body Mass Index | 1 | 2020 | 713 | 0.580 |
Why?
| Adipose Tissue, Brown | 1 | 2016 | 45 | 0.570 |
Why?
| Trophoblasts | 2 | 2015 | 29 | 0.570 |
Why?
| Oxidants | 3 | 2007 | 64 | 0.550 |
Why?
| Adiposity | 4 | 2020 | 142 | 0.550 |
Why?
| Placentation | 1 | 2015 | 9 | 0.550 |
Why?
| Adenosine Triphosphate | 1 | 2016 | 242 | 0.540 |
Why?
| Diet | 1 | 2020 | 598 | 0.540 |
Why?
| Calcium | 4 | 2017 | 432 | 0.520 |
Why?
| Rats, Sprague-Dawley | 14 | 2011 | 1663 | 0.480 |
Why?
| Transcriptome | 2 | 2015 | 346 | 0.470 |
Why?
| Epigenesis, Genetic | 2 | 2017 | 399 | 0.450 |
Why?
| Intracellular Signaling Peptides and Proteins | 3 | 2011 | 151 | 0.430 |
Why?
| Pregnancy | 10 | 2020 | 2620 | 0.420 |
Why?
| Insulin Resistance | 1 | 2014 | 300 | 0.410 |
Why?
| Rats | 14 | 2011 | 3415 | 0.400 |
Why?
| Receptors, Endothelin | 2 | 2008 | 6 | 0.390 |
Why?
| Nifedipine | 1 | 2009 | 24 | 0.370 |
Why?
| Gene Expression Regulation | 2 | 2017 | 1062 | 0.360 |
Why?
| Drug Resistance | 1 | 2009 | 74 | 0.360 |
Why?
| Calcium Channel Blockers | 1 | 2009 | 72 | 0.350 |
Why?
| Inflammation | 1 | 2014 | 674 | 0.350 |
Why?
| Vasodilator Agents | 1 | 2009 | 111 | 0.340 |
Why?
| Vena Cava, Inferior | 2 | 2007 | 78 | 0.330 |
Why?
| Animals | 21 | 2018 | 14385 | 0.330 |
Why?
| Receptor, Endothelin B | 1 | 2008 | 3 | 0.330 |
Why?
| Muscle Contraction | 4 | 2017 | 109 | 0.320 |
Why?
| Blotting, Western | 5 | 2014 | 683 | 0.300 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2006 | 26 | 0.290 |
Why?
| src-Family Kinases | 1 | 2006 | 54 | 0.280 |
Why?
| Infant, Newborn | 6 | 2020 | 2907 | 0.280 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 101 | 0.280 |
Why?
| Male | 21 | 2020 | 27334 | 0.280 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 99 | 0.280 |
Why?
| Cohort Studies | 3 | 2020 | 1543 | 0.270 |
Why?
| Diet, High-Fat | 2 | 2018 | 216 | 0.270 |
Why?
| Nitric Oxide | 1 | 2006 | 298 | 0.240 |
Why?
| Early Growth Response Protein 1 | 2 | 2014 | 39 | 0.230 |
Why?
| Venous Valves | 1 | 2022 | 2 | 0.220 |
Why?
| Female | 13 | 2020 | 28441 | 0.210 |
Why?
| Bioprosthesis | 1 | 2022 | 30 | 0.210 |
Why?
| Mesenteric Arteries | 2 | 2012 | 45 | 0.200 |
Why?
| CpG Islands | 1 | 2020 | 104 | 0.180 |
Why?
| Humans | 15 | 2022 | 54284 | 0.170 |
Why?
| Angiotensin II | 2 | 2012 | 166 | 0.170 |
Why?
| Regression Analysis | 2 | 2017 | 445 | 0.170 |
Why?
| Antioxidants | 2 | 2015 | 297 | 0.170 |
Why?
| Epigenomics | 2 | 2016 | 67 | 0.170 |
Why?
| Prenatal Exposure Delayed Effects | 2 | 2017 | 173 | 0.160 |
Why?
| Myocytes, Smooth Muscle | 3 | 2017 | 92 | 0.160 |
Why?
| Maternal Exposure | 1 | 2018 | 87 | 0.160 |
Why?
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 8 | 0.160 |
Why?
| AMP-Activated Protein Kinases | 1 | 2017 | 29 | 0.150 |
Why?
| Fatty Liver | 1 | 2018 | 129 | 0.150 |
Why?
| Escherichia coli Proteins | 3 | 2015 | 100 | 0.150 |
Why?
| Mothers | 1 | 2020 | 247 | 0.150 |
Why?
| Overweight | 1 | 2020 | 240 | 0.150 |
Why?
| Body Composition | 1 | 2019 | 349 | 0.150 |
Why?
| Hydroxybenzoates | 2 | 2015 | 23 | 0.150 |
Why?
| Reactive Oxygen Species | 3 | 2015 | 491 | 0.140 |
Why?
| Parents | 1 | 2019 | 344 | 0.140 |
Why?
| Lipid Metabolism | 2 | 2018 | 194 | 0.140 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 206 | 0.140 |
Why?
| Vena Cava, Superior | 2 | 2008 | 24 | 0.140 |
Why?
| rho-Associated Kinases | 2 | 2006 | 20 | 0.140 |
Why?
| Estradiol | 1 | 2017 | 219 | 0.140 |
Why?
| Fetal Development | 1 | 2016 | 64 | 0.140 |
Why?
| Arteries | 2 | 2007 | 101 | 0.140 |
Why?
| Cell Fusion | 1 | 2015 | 23 | 0.140 |
Why?
| Adult | 5 | 2020 | 14207 | 0.140 |
Why?
| Coronary Vessels | 1 | 2017 | 197 | 0.130 |
Why?
| Enzyme Inhibitors | 2 | 2009 | 446 | 0.130 |
Why?
| Chlorogenic Acid | 1 | 2015 | 8 | 0.130 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 673 | 0.130 |
Why?
| Gene Expression Profiling | 3 | 2017 | 1138 | 0.130 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2014 | 65 | 0.120 |
Why?
| Adipogenesis | 1 | 2014 | 52 | 0.120 |
Why?
| Microarray Analysis | 1 | 2014 | 84 | 0.120 |
Why?
| Proteins | 1 | 2017 | 376 | 0.120 |
Why?
| Anthropometry | 1 | 2014 | 96 | 0.120 |
Why?
| Cell Adhesion Molecules | 1 | 2014 | 87 | 0.120 |
Why?
| DNA Primers | 1 | 2014 | 225 | 0.120 |
Why?
| Disease Models, Animal | 2 | 2017 | 1639 | 0.120 |
Why?
| Fruit | 1 | 2015 | 143 | 0.120 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 95 | 0.120 |
Why?
| Anti-Inflammatory Agents | 1 | 2015 | 175 | 0.120 |
Why?
| Oxidoreductases | 2 | 2004 | 62 | 0.110 |
Why?
| Patch-Clamp Techniques | 2 | 2011 | 148 | 0.110 |
Why?
| Membrane Potentials | 2 | 2011 | 139 | 0.110 |
Why?
| Histones | 1 | 2015 | 335 | 0.110 |
Why?
| Potassium Channels | 1 | 2013 | 41 | 0.110 |
Why?
| Potassium Chloride | 2 | 2009 | 18 | 0.110 |
Why?
| Calcium Channels | 1 | 2013 | 59 | 0.110 |
Why?
| Blood Pressure | 4 | 2012 | 587 | 0.110 |
Why?
| Leptin | 1 | 2014 | 154 | 0.110 |
Why?
| Analysis of Variance | 1 | 2014 | 635 | 0.110 |
Why?
| Post-Synaptic Density | 1 | 2011 | 4 | 0.100 |
Why?
| Antihypertensive Agents | 1 | 2013 | 139 | 0.100 |
Why?
| Shaker Superfamily of Potassium Channels | 1 | 2011 | 10 | 0.100 |
Why?
| Vasoconstrictor Agents | 2 | 2009 | 88 | 0.100 |
Why?
| Insulin | 1 | 2014 | 510 | 0.100 |
Why?
| Cerebral Arteries | 1 | 2011 | 37 | 0.100 |
Why?
| Escherichia coli | 2 | 2004 | 250 | 0.100 |
Why?
| Cell Differentiation | 1 | 2014 | 720 | 0.100 |
Why?
| Immunohistochemistry | 3 | 2011 | 1089 | 0.100 |
Why?
| Renal Circulation | 1 | 2011 | 82 | 0.100 |
Why?
| Oxidative Stress | 2 | 2007 | 958 | 0.100 |
Why?
| Potassium Channel Blockers | 2 | 2011 | 18 | 0.100 |
Why?
| Up-Regulation | 1 | 2012 | 508 | 0.100 |
Why?
| Matrix Metalloproteinases | 2 | 2007 | 52 | 0.090 |
Why?
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2009 | 8 | 0.090 |
Why?
| Mesenteric Veins | 1 | 2009 | 14 | 0.090 |
Why?
| Chelating Agents | 1 | 2009 | 28 | 0.090 |
Why?
| Young Adult | 1 | 2020 | 4318 | 0.090 |
Why?
| Desoxycorticosterone | 2 | 2007 | 5 | 0.090 |
Why?
| Adaptation, Physiological | 2 | 2007 | 101 | 0.090 |
Why?
| Hemodynamics | 1 | 2011 | 290 | 0.090 |
Why?
| Sodium Chloride | 2 | 2007 | 67 | 0.090 |
Why?
| Membrane Proteins | 1 | 2011 | 389 | 0.080 |
Why?
| Animals, Genetically Modified | 1 | 2008 | 52 | 0.080 |
Why?
| Sepsis | 1 | 2011 | 251 | 0.080 |
Why?
| Tachyphylaxis | 1 | 2007 | 2 | 0.080 |
Why?
| beta-Cyclodextrins | 1 | 2007 | 18 | 0.080 |
Why?
| Norepinephrine | 2 | 2007 | 119 | 0.080 |
Why?
| Myosin Heavy Chains | 1 | 2007 | 19 | 0.080 |
Why?
| Data Interpretation, Statistical | 1 | 2008 | 177 | 0.080 |
Why?
| Thromboxane A2 | 1 | 2006 | 23 | 0.070 |
Why?
| Spin Labels | 1 | 2006 | 7 | 0.070 |
Why?
| Nitroarginine | 1 | 2006 | 8 | 0.070 |
Why?
| Ganglia, Sympathetic | 1 | 2006 | 3 | 0.070 |
Why?
| Cyclic N-Oxides | 1 | 2006 | 15 | 0.070 |
Why?
| Peptide Fragments | 1 | 2007 | 242 | 0.070 |
Why?
| Superoxides | 1 | 2006 | 61 | 0.070 |
Why?
| Acute Kidney Injury | 1 | 2011 | 403 | 0.070 |
Why?
| Ouabain | 1 | 2006 | 29 | 0.070 |
Why?
| Extracellular Fluid | 1 | 2006 | 19 | 0.070 |
Why?
| Nitric Oxide Synthase | 1 | 2006 | 102 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 1 | 2009 | 1476 | 0.070 |
Why?
| Myosin-Light-Chain Phosphatase | 1 | 2005 | 2 | 0.070 |
Why?
| Copper | 2 | 2004 | 48 | 0.070 |
Why?
| rhoA GTP-Binding Protein | 1 | 2005 | 8 | 0.070 |
Why?
| Sodium-Potassium-Exchanging ATPase | 1 | 2006 | 68 | 0.070 |
Why?
| Drug Synergism | 1 | 2006 | 171 | 0.070 |
Why?
| Siderophores | 1 | 2004 | 11 | 0.060 |
Why?
| Thoracic Arteries | 1 | 2004 | 2 | 0.060 |
Why?
| Norfenfluramine | 1 | 2004 | 2 | 0.060 |
Why?
| Fenfluramine | 1 | 2004 | 7 | 0.060 |
Why?
| Atherosclerosis | 1 | 2007 | 249 | 0.060 |
Why?
| Phosphorylation | 1 | 2005 | 614 | 0.060 |
Why?
| Interleukin-6 | 2 | 2015 | 315 | 0.050 |
Why?
| Glutaral | 1 | 2022 | 2 | 0.050 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2015 | 434 | 0.050 |
Why?
| Benchmarking | 1 | 2022 | 73 | 0.050 |
Why?
| Temperature | 1 | 2022 | 177 | 0.050 |
Why?
| Mice | 3 | 2018 | 6413 | 0.050 |
Why?
| Child, Preschool | 2 | 2020 | 4147 | 0.050 |
Why?
| Mice, Inbred C57BL | 2 | 2017 | 1999 | 0.040 |
Why?
| Signal Transduction | 1 | 2006 | 1753 | 0.040 |
Why?
| Insulin-Like Growth Factor I | 1 | 2019 | 137 | 0.040 |
Why?
| Infant | 2 | 2020 | 3817 | 0.040 |
Why?
| Metagenomics | 1 | 2018 | 38 | 0.040 |
Why?
| Metagenome | 1 | 2018 | 44 | 0.040 |
Why?
| Biodiversity | 1 | 2018 | 60 | 0.040 |
Why?
| Bile Acids and Salts | 1 | 2018 | 76 | 0.040 |
Why?
| Metabolic Networks and Pathways | 1 | 2018 | 104 | 0.040 |
Why?
| Gestational Age | 1 | 2019 | 435 | 0.040 |
Why?
| Phylogeny | 1 | 2018 | 269 | 0.040 |
Why?
| Overnutrition | 1 | 2017 | 10 | 0.040 |
Why?
| Estrogen Receptor beta | 1 | 2017 | 56 | 0.040 |
Why?
| Choline Deficiency | 1 | 2017 | 23 | 0.040 |
Why?
| RNA, Messenger | 2 | 2014 | 1202 | 0.040 |
Why?
| Choline | 1 | 2017 | 63 | 0.040 |
Why?
| Estrogen Receptor alpha | 1 | 2017 | 95 | 0.040 |
Why?
| Sex Characteristics | 1 | 2018 | 214 | 0.040 |
Why?
| Swine | 1 | 2017 | 431 | 0.030 |
Why?
| Methionine | 1 | 2017 | 146 | 0.030 |
Why?
| Anisotropy | 1 | 2015 | 63 | 0.030 |
Why?
| Erythrocytes | 1 | 2015 | 98 | 0.030 |
Why?
| Diffusion Tensor Imaging | 1 | 2015 | 97 | 0.030 |
Why?
| Cell Culture Techniques | 1 | 2015 | 112 | 0.030 |
Why?
| Culture Media | 1 | 2014 | 100 | 0.030 |
Why?
| Activating Transcription Factor 3 | 1 | 2013 | 9 | 0.030 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2015 | 377 | 0.030 |
Why?
| Cells, Cultured | 1 | 2017 | 1737 | 0.030 |
Why?
| Palmitates | 1 | 2013 | 28 | 0.030 |
Why?
| Child Development | 1 | 2015 | 204 | 0.030 |
Why?
| Ion Channel Gating | 1 | 2013 | 47 | 0.030 |
Why?
| NF-kappa B | 1 | 2015 | 335 | 0.030 |
Why?
| Interleukin-8 | 1 | 2013 | 97 | 0.030 |
Why?
| Serum Response Factor | 1 | 2013 | 41 | 0.030 |
Why?
| Protein Subunits | 1 | 2013 | 85 | 0.030 |
Why?
| Genotype | 1 | 2014 | 599 | 0.030 |
Why?
| MAP Kinase Signaling System | 1 | 2013 | 133 | 0.030 |
Why?
| Molecular Targeted Therapy | 1 | 2013 | 128 | 0.030 |
Why?
| Spider Venoms | 1 | 2011 | 6 | 0.030 |
Why?
| Oligonucleotides, Antisense | 1 | 2011 | 29 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2011 | 125 | 0.030 |
Why?
| Ligation | 1 | 2011 | 64 | 0.020 |
Why?
| Capillary Permeability | 1 | 2011 | 40 | 0.020 |
Why?
| Telemetry | 1 | 2011 | 36 | 0.020 |
Why?
| Peritonitis | 1 | 2011 | 33 | 0.020 |
Why?
| Multiple Organ Failure | 1 | 2011 | 56 | 0.020 |
Why?
| Phenotype | 1 | 2014 | 820 | 0.020 |
Why?
| Blood Flow Velocity | 1 | 2011 | 114 | 0.020 |
Why?
| Cecum | 1 | 2011 | 72 | 0.020 |
Why?
| Microcirculation | 1 | 2011 | 89 | 0.020 |
Why?
| Hypothermia | 1 | 2011 | 41 | 0.020 |
Why?
| Fluid Therapy | 1 | 2011 | 87 | 0.020 |
Why?
| Liver | 1 | 2017 | 1225 | 0.020 |
Why?
| Cell Line | 1 | 2013 | 1153 | 0.020 |
Why?
| Animals, Newborn | 1 | 2011 | 396 | 0.020 |
Why?
| Chymases | 1 | 2007 | 3 | 0.020 |
Why?
| Organophosphonates | 1 | 2007 | 5 | 0.020 |
Why?
| Glycopeptides | 1 | 2007 | 15 | 0.020 |
Why?
| Isometric Contraction | 1 | 2007 | 25 | 0.020 |
Why?
| Aspartic Acid Endopeptidases | 1 | 2007 | 17 | 0.020 |
Why?
| Dipeptides | 1 | 2007 | 20 | 0.020 |
Why?
| Minocycline | 1 | 2007 | 18 | 0.020 |
Why?
| Caveolin 1 | 1 | 2007 | 21 | 0.020 |
Why?
| Immunoprecipitation | 1 | 2007 | 73 | 0.020 |
Why?
| Tetrazoles | 1 | 2007 | 43 | 0.020 |
Why?
| Microscopy, Electron, Transmission | 1 | 2007 | 87 | 0.020 |
Why?
| Protease Inhibitors | 1 | 2007 | 64 | 0.020 |
Why?
| Receptor, Angiotensin, Type 1 | 1 | 2007 | 60 | 0.020 |
Why?
| Cell Size | 1 | 2007 | 45 | 0.020 |
Why?
| Metalloendopeptidases | 1 | 2007 | 82 | 0.020 |
Why?
| Brain | 1 | 2015 | 1387 | 0.020 |
Why?
| Kidney | 1 | 2011 | 820 | 0.020 |
Why?
| Enterobactin | 1 | 2004 | 2 | 0.020 |
Why?
| Artificial Gene Fusion | 1 | 2004 | 13 | 0.020 |
Why?
| beta-Galactosidase | 1 | 2004 | 42 | 0.020 |
Why?
| Genes, Bacterial | 1 | 2004 | 67 | 0.020 |
Why?
| Genes, Reporter | 1 | 2004 | 98 | 0.020 |
Why?
| Sympathectomy | 1 | 2004 | 2 | 0.020 |
Why?
| Ergolines | 1 | 2004 | 3 | 0.020 |
Why?
| Prazosin | 1 | 2004 | 11 | 0.020 |
Why?
| Ketanserin | 1 | 2004 | 9 | 0.020 |
Why?
| Serotonin 5-HT2 Receptor Antagonists | 1 | 2004 | 9 | 0.020 |
Why?
| Gene Expression | 1 | 2007 | 664 | 0.020 |
Why?
| Receptors, Adrenergic, alpha | 1 | 2004 | 16 | 0.020 |
Why?
| Receptor, Serotonin, 5-HT2C | 1 | 2004 | 7 | 0.020 |
Why?
| Serotonin Antagonists | 1 | 2004 | 31 | 0.020 |
Why?
| Sympathetic Nervous System | 1 | 2004 | 21 | 0.020 |
Why?
| Receptor, Serotonin, 5-HT2A | 1 | 2004 | 13 | 0.020 |
Why?
| Drug Resistance, Bacterial | 1 | 2004 | 81 | 0.020 |
Why?
| Gene Deletion | 1 | 2004 | 293 | 0.010 |
Why?
| Oxidation-Reduction | 1 | 2004 | 382 | 0.010 |
Why?
| Repressor Proteins | 1 | 2004 | 165 | 0.010 |
Why?
| Aorta | 1 | 2004 | 177 | 0.010 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2004 | 244 | 0.010 |
Why?
| Electron Transport | 1 | 2002 | 35 | 0.010 |
Why?
| Crystallography, X-Ray | 1 | 2002 | 178 | 0.010 |
Why?
| Protein Structure, Tertiary | 1 | 2002 | 289 | 0.010 |
Why?
| Homeostasis | 1 | 2002 | 223 | 0.010 |
Why?
| Models, Molecular | 1 | 2002 | 423 | 0.010 |
Why?
| Bacterial Proteins | 1 | 2004 | 454 | 0.010 |
Why?
| Kinetics | 1 | 2002 | 692 | 0.010 |
Why?
| Anti-Bacterial Agents | 1 | 2004 | 820 | 0.010 |
Why?
|
|
Thakali's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|